专题：Biological Agents for Bioterrorism

This cluster of papers focuses on the study of biological agents with potential for bioterrorism, including anthrax, tularemia, Bacillus cereus, and Francisella tularensis. The research covers various aspects such as pathogenesis, genomic analysis, inhalational anthrax cases, toxins, and public health assessments related to these biological agents.
最新文献
Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study

article Full Text OpenAlex

Introducing institutional design principles for transforming on-ground biosecurity

article Full Text OpenAlex

Skyrocketing mpox outbreak in Sierra Leone raises fears of wider spread

article Full Text OpenAlex

Awareness and willingness towards Mpox vaccination among men who have sex with men seeking HIV-related services

article Full Text OpenAlex

Clinical and epidemiological characteristics among probable and confirmed patients with mpox in Sierra Leone reported from January to May 2025

preprint Full Text OpenAlex

Characteristics of the first confirmed case of human infection with mpox virus clade Ib in China

article Full Text OpenAlex

Horizontal gene transfer of molecular weapons can reshape bacterial competition

article Full Text OpenAlex

Genomics reveals zoonotic and sustained human Mpox spread in West Africa

article Full Text OpenAlex

Streptobacillus moniliformis (Rat-Bite Fever)

book-chapter Full Text OpenAlex

Dual-use capabilities of concern of biological AI models

article Full Text OpenAlex

近5年高被引文献
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

article Full Text OpenAlex 1845 FWCI154.775

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

article Full Text OpenAlex 1814 FWCI110.622

Clinical features and management of human monkeypox: a retrospective observational study in the UK

article Full Text OpenAlex 1131 FWCI94.829

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

article Full Text OpenAlex 938 FWCI108.472

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

article Full Text OpenAlex 799 FWCI92.311

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

article Full Text OpenAlex 735 FWCI83.384

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance

article Full Text OpenAlex 649 FWCI73.361

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

article Full Text OpenAlex 642 FWCI72.804

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex

article Full Text OpenAlex 622 FWCI71.733

Antibody evasion by the P.1 strain of SARS-CoV-2

article Full Text OpenAlex 618 FWCI40.058